IP Library Granted Patent US 8,652,442
Granted Patent B2
US 8,652,442 · App. 13/127,448 · Granted Feb 18, 2014

Bioluminescence imaging of myeloperoxidase activity in vivo, methods, compositions and apparatuses therefor

Inventors: David Piwnica-Worms (Ladue, MO); Shimon Gross (St. Yavne, IL); Vijay Sharma (Wildwood, MO); Seth Gammon (St. Louis, MO)
Assignee: Washington University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,652,442
App. No.
13/127,448
Granted
Feb 18, 2014
Kind
B2
Abstract

Methods of imaging distribution of myeloperoxidase activity in a subject are disclosed. These methods include the use of bioluminescent substrates, including luminol and wavelength-shifted analogues of luminol. Bioluminescent myeloperoxidase substrates that emit light at longer wavelengths compared to luminol are shown to be useful for imaging myeloperoxidase activity in vivo. The disclosed methods can be used for imaging sites of inflammation and other pathological conditions associated with abnormal levels of MPO activity in vivo. Methods of synthesis of luminol analogues are also disclosed.

Claims (9)

1. A compound or salt thereof of structure

wherein R 2 and R 3 are each selected from the group consisting of H, C 1 -C 20 alkyl, C 1 -C 20 alkenyl, C 1 -C 20 alkynyl, C 1 -C 20 aryl, C 1 -C 20 heteroaryl, C 1 -C 20 carboxyl, C 1 -C 20 carbonyl, an ester, an ether, an amine, an amide, a nitro, a nitrite, a sulfate, a sulfide, a sulfonamide, a phosphate, a borate, and a halogen; at least one of R 1 or R 4 is

wherein X 1 is selected from the group consisting of H, C 1 -C 20 alkyl, C 1 -C 20 alkenyl, C 1 -C 20 alkynyl, C 1 -C 20 aryl, C 1 -C 20 heteroaryl, C 1 -C 20 carboxyl, C 1 -C 20 carbonyl, an ester, an ether, an amine, an amide, a nitro, a nitrile, a sulfate, a sulfide, a sulfonamide, a phosphate, a borate, and a halogen; X is selected from the group consisting of a C 1 -C 20 alkyl, C 1 -C 20 heteroalkyl C 1 -C 20 alkenyl, C 1 -C 20 heteroalkenyl, C 1 -C 20 alkynyl, C 1 -C 20 heteroalkynyl, C 1 -C 20 aryl, C 1 -C 20 heteroaryl, C 1 -C 20 carboxyl, C 1 -C 20 carbonyl, an ester, an ether, an amine, an amide, and a sulfonamide; Y is selected from the group consisting of an amide, a sulfonamide, an acetyl, a ketone, an ester, and an ether; n is an integer from 0 to 20; X 2 and X 3 are each selected from the group consisting of H, C 1 -C 20 alkyl, C 1 -C 20 alkenyl, C 1 -C 20 alkynyl, C 1 -C 20 aryl, C 1 -C 20 heteroaryl, C 1 -C 20 carboxyl, C 1 -C 20 carbonyl, an ester, an ether, an amine, an amide, a nitro, a nitrile, a sulfate, a sulfide, a sulfonamide, a phosphate, a borate and a halogen; and wherein Z is a light emitting moiety.

2. A compound or salt thereof in accordance with claim 1 , wherein an X 2 and an X 3 together comprise an aliphatic or aromatic cyclic moiety.

3. A compound or salt thereof in accordance with claim 1 , wherein R 2 and R 3 together comprise an aliphatic or aromatic cyclic moiety.

4. A compound or salt thereof in accordance with claim 1 , wherein Z is a fluorescent moiety selected from the group consisting of a fluorescein, a squaraine, a rotaxane, a rhodamine, a Texas Red, an Oregon Green, a Cascade Yellow, a Lucifer Yellow, an AlexaFluor, a CY5, a CY3, and a quantum dot.

5. A compound or salt thereof in accordance with claim 1 , having the following formula:

6. A compound or salt thereof of structure

(Lumino)-Glycine-Texas Red).

Continuity (2)
Provisional Application 61110727 · Nov 3, 2008
Related Publication 20110250145A1 · Oct 13, 2011